EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Sex-specific Association of Chronic Proton Pump Inhibitor Use With Reduced Bone Density and Quality

Fabio Bioletto iD, Alessia Pusterla, Federica Fraire, Lorenzo Sauro, Michela Presti, Emanuela Arvat iD, Ezio Ghigo, Massimo Procopio, Marco Barale

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae598 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Fabio Bioletto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Turin, 10126, Italy. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Bone Density, Cancellous Bone, Osteoporosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Chronic use of proton pump inhibitors (PPIs) has been associated with an increase in bone fragility. However, evidence on the effect of chronic PPI use on bone density is conflicting, and data on bone microarchitectural quality are scarce.

Objective

The primary aim of this study was to evaluate whether trabecular bone microarchitecture, assessed by trabecular bone score (TBS), is altered in chronic PPI users. The association between PPI use and bone density was also evaluated as a secondary endpoint.

Methods

We extracted individual patient data from the 2005 to 2008 cycles of the population-based National Health and Nutrition Examination Survey (NHANES), in which lumbar spine dual-energy X-ray absorptiometry scans were acquired. TBS values were calculated from dual-energy X-ray absorptiometry images using a dedicated software. Multivariable linear regression analyses stratified by sex were performed to evaluate the association of chronic PPI use with TBS and bone mineral density (BMD), adjusting for relevant confounders.

Results

A total of 7478 subjects were included (3961 men, 3517 women). After adjustment for relevant confounders, chronic PPI use was associated with a worse bone health profile in men, with lower TBS (−0.039; 95% CI, −0.058 to −0.020; P < .001), lumbar spine T-score (−0.27; 95% CI, −0.51 to −0.04; P = .023), total hip T-score (−0.21; 95% CI, −0.41 to −0.01; P = .041), and femoral neck T-score (−0.22; 95% CI, −0.44 to −0.00; P = .047). Notably, the association between chronic PPI use and degraded TBS remained statistically significant even after further adjustment for BMD at lumbar spine and femoral neck (−0.026; 95% CI, −0.039 to −0.012; P = .001). In contrast, no significant association was observed between chronic PPI use and either TBS or BMD in women.

Conclusion

Chronic PPI use is associated with degraded trabecular bone quality in men, even after adjustment for BMD. No association was observed in women.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsBone DensityCancellous BoneOsteoporosisHumansFemaleMaleMiddle AgedAbsorptiometry, PhotonAgedAdultNutrition SurveysLumbar VertebraeSex FactorsCross-Sectional Studies

Stichwörter der Autor:innen

PPIbone densitybone qualityosteoporosisproton pump inhibitorstrabecular bone score

Substanzen

Proton Pump Inhibitors

Autor:innen und Institutionen

  • Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Turin, 10126, Italy.
  • Division of Oncological Endocrinology, Department of Medical Sciences, University of Turin, Turin, 10126, Italy.

ORCID-Profile: Fabio Bioletto, Emanuela Arvat

Zitieren

APA

Bioletto, F., Pusterla, A., Fraire, F., Sauro, L., Presti, M., Arvat, E., Ghigo, E., Procopio, M., & Barale, M. (2025). Sex-specific Association of Chronic Proton Pump Inhibitor Use With Reduced Bone Density and Quality. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae598

Vancouver

Bioletto F, Pusterla A, Fraire F, Sauro L, Presti M, Arvat E, et al. Sex-specific Association of Chronic Proton Pump Inhibitor Use With Reduced Bone Density and Quality. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae598

BibTeX
@article{Bioletto2025,
  author = {Bioletto, Fabio and Pusterla, Alessia and Fraire, Federica and Sauro, Lorenzo and Presti, Michela and Arvat, Emanuela and Ghigo, Ezio and Procopio, Massimo and Barale, Marco},
  title = {Sex-specific Association of Chronic Proton Pump Inhibitor Use With Reduced Bone Density and Quality},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae598}
}
Kostenlos starten →